{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:34:41Z","timestamp":1783092881590,"version":"3.54.6"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00511","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:34:13Z","timestamp":1576730053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Understanding Childhood Neuroimmune Diseases of the Central Nervous System"],"prefix":"10.3389","volume":"7","author":[{"given":"Sara","family":"Matricardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Farello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Savasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41582-018-0024-9","article-title":"Neuroimmune disorders of the central nervous system in children in the molecular era","volume":"14","author":"Wells","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1212\/WNL.0000000000002878","article-title":"Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders","volume":"87","author":"Rostasy","year":"2016","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00415-012-6441-6","article-title":"Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study","volume":"259","author":"Ketelslegers","year":"2012","journal-title":"J Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/ene.12371","article-title":"Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009\u20132011)","volume":"21","author":"Reinhardt","year":"2014","journal-title":"Eur J Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","article-title":"Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children","volume":"77","author":"Langer-Gould","year":"2011","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1352458512445944","article-title":"Paediatric acquired demyelinating syndrome: incidence, clinical and magnetic resonance imaging features","volume":"19","author":"Absoud","year":"2013","journal-title":"Mult Scler"},{"key":"B8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1474-4422(11)70045-X","article-title":"Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study","volume":"10","author":"Banwell","year":"2011","journal-title":"Lancet Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1212\/WNL.0000000000002822","article-title":"Pediatric optic neuritis","volume":"87","author":"Yeh","year":"2016","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1212\/WNL.0000000000002820","article-title":"Pediatric transverse myelitis","volume":"87","author":"Absoud","year":"2016","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1177\/1352458513484377","article-title":"Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria","volume":"19","author":"Tantsis","year":"2013","journal-title":"Mult Scler."},{"key":"B14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00431-006-0249-2","article-title":"Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey","volume":"166","author":"Pohl","year":"2007","journal-title":"Eur J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/EDE.0000000000000176","article-title":"Geoepidemiology of acute disseminated encephalomyelitis","volume":"25","author":"Pellegrino","year":"2014","journal-title":"Epidemiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","article-title":"Acute disseminated encephalomyelitis","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1212\/01.wnl.0000259422.44235.a8","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders","volume":"68","author":"Krupp","year":"2007","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/brain\/awp321","article-title":"Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis","volume":"133","author":"Young","year":"2010","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11940-012-0170-0","article-title":"Treatment of acute disseminated encephalomyelitis","volume":"14","author":"Pohl","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458510382554","article-title":"Severe acute disseminated encephalomyelitis: a pediatric intensive care population-based study","volume":"17","author":"Absoud","year":"2011","journal-title":"Mult Scler"},{"key":"B24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/1352458510390068","article-title":"Disease course and outcome of acute disseminated encephalomyelitis in more severe in adults than children","volume":"17","author":"Ketelslegers","year":"2011","journal-title":"Mult Scler"},{"key":"B25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pediatrneurol.2013.12.006","article-title":"Long-term neurocognitive outcome and quality of life in pediatric acute disseminated encephalomyelitis","volume":"50","author":"Suppiej","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS","volume":"86","author":"Jurynczyk","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1474-4422(16)30043-6","article-title":"Atypical inflammatory demyelinating syndromes of the CNS","volume":"15","author":"Hardy","year":"2016","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"398259","DOI":"10.1155\/2013\/398259","article-title":"Ultrahigh-field MR (7 T) imaging of brain lesions in neuromyelitis optica","volume":"2013","author":"Kister","year":"2013","journal-title":"Mult Scler Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1177\/1352458513476562","article-title":"Longitudinal follow-up of vision in a neuromyelitis optica cohort","volume":"19","author":"Bouyon","year":"2013","journal-title":"Mult Scler."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa067597","article-title":"Natural history of multiple sclerosis with childhood onset","volume":"356","author":"Renoux","year":"2007","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1352458511417479","article-title":"Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis","volume":"18","author":"Cossburn","year":"2012","journal-title":"Mult Scler"},{"key":"B34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2008.09.004","article-title":"Pedistric-onset multiple sclerosis in African-American black and European-origin white patients","volume":"40","author":"Boster","year":"2009","journal-title":"Pediatr Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.59.7.1006","article-title":"Early onset multiple sclerosis: a longitudinal study","volume":"59","author":"Boiko","year":"2002","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/1744666X.2017.1360135","article-title":"An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future","volume":"13","author":"Gordon-Lipkin","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revision to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1212\/WNL.0000000000003028","article-title":"Peditric multiple sclerosis. Clinical features and outcome","volume":"87","author":"Waldman","year":"2016","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pediatrneurol.2013.10.009","article-title":"Current advances in childhood absence epilepsy","volume":"50","author":"Matricardi","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/pop.2012.1565","article-title":"Epileptic seizures in early-onset multiple sclerosis","volume":"15","author":"Etemadifar","year":"2012","journal-title":"Arch Iran Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1474-4422(14)70093-6","article-title":"Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research","volume":"13","author":"Waldman","year":"2014","journal-title":"Lancet Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1212\/WNL.0000000000002880","article-title":"International pediatric MS study group global members symposium report","volume":"87","author":"Wassmer","year":"2016","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1212\/WNL.0000000000002823","article-title":"Pediatric multiple sclerosis: conventional first-line treatment and general management","volume":"87","author":"Ghezzi","year":"2016","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/157015910791233141","article-title":"Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update","volume":"8","author":"Spalice","year":"2010","journal-title":"Curr Neuropharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/WNL.0000000000006583","article-title":"Misdiagnosis of multiple sclerosis: impact of the 2017 McDonald criteria on clinical practice","volume":"92","author":"Solomon","year":"2019","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrneurol.2017.106","article-title":"The tension between early diagnosis and misdiagnosis in multiple sclerosis","volume":"13","author":"Solomon","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bcp.2018.08.037","article-title":"Gut microbiota, cannabinoid system and neuroimmune interactions: new perspectives in multiple sclerosis","volume":"157","author":"Mestre","year":"2018","journal-title":"Biochem Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev Med Child Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/dmcn.14267","article-title":"Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis","volume":"61","author":"Nosadini","year":"2019","journal-title":"Dev med Child Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","article-title":"Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients","volume":"162","author":"Armangue","year":"2013","journal-title":"J Pediatr"},{"key":"B57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.seizure.2015.02.005","article-title":"Focal seizure, focal dyskinesia, or both? A complex motor phenomenon reveals anti-NMDAR encephalitis","volume":"27","author":"Freri","year":"2015","journal-title":"Seizure"},{"key":"B61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejpn.2018.01.012","article-title":"Pediatric NMDAR encephalitis: a single center observation study with a closer look at movement disorders","volume":"22","author":"Granata","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert Rev Neurother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00415-016-8056-9","article-title":"Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis","volume":"263","author":"Matricardi","year":"2016","journal-title":"J Neurol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13803395.2017.1329408","article-title":"Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: a systematic review","volume":"40","author":"McKeon","year":"2018","journal-title":"J Clin Exp Neuropsychol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejpn.2017.08.004","article-title":"Limbic encephalitis with LGI1 antibodies in a 14-year-old boy","volume":"22","author":"Schimmel","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pediatrneurol.2010.10.015","article-title":"Neuronal voltage-gated potassium channel complex autoimmunity in children","volume":"44","author":"Dhamija","year":"2011","journal-title":"Pediatr Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/adc.2010.183897","article-title":"Limbic encephalitis in children and adolescents","volume":"96","author":"Haberlandt","year":"2011","journal-title":"Arch Dis Child"},{"key":"B75","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1212\/WNL.0000000000001922","article-title":"Clinical relevance of voltage-gated potassium channel\u2013complex antibodies in children","volume":"85","author":"Hacohen","year":"2015","journal-title":"Neurology."},{"key":"B76","doi-asserted-by":"publisher","first-page":"577008","DOI":"10.1016\/j.jneuroim.2019.577008","article-title":"LGI1 and CASPR2 autoimmunity in children: systematic literature review and report od a young girl with Morvan syndrome","volume":"335","author":"Nosadini","year":"2019","journal-title":"J Neuroimmunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.25310","article-title":"LGI1 and CASPR2 neurological autoimmunity in children","volume":"84","author":"Lopez-Chiriboga","year":"2018","journal-title":"Ann Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1212\/WNL.0b013e3182143552","article-title":"VGKC antibodies in pediatric encephalitis presenting with status epilepticus","volume":"76","author":"Suleiman","year":"2011","journal-title":"Neurology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1469-8749.2011.04096.x","article-title":"Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies","volume":"53","author":"Suleiman","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA receptor \u03b11 and \u03b32 subunits: clinical and serologic characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejpn.2017.11.005","article-title":"Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies","volume":"22","author":"Caputo","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger","year":"2013","journal-title":"Neurology."},{"key":"B86","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","article-title":"GABAB receptor autoantibody frequency in service serologic evaluation","volume":"81","author":"Jeffery","year":"2013","journal-title":"Neurology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/acn3.43","article-title":"Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis","volume":"1","author":"Gleichman","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain."},{"key":"B89","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamaneurol.2013.1872","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies","volume":"70","author":"Dam\u00e1sio","year":"2013","journal-title":"JAMA Neurol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ejpn.2016.08.013","article-title":"Focal status epilepticus and progressive dyskinesia: a novel phenotype for glycine receptor antibody-mediated neurological disease in children","volume":"21","author":"Chan","year":"2017","journal-title":"Eur J Paediatr Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B93","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology."},{"key":"B95","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","article-title":"Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients","volume":"89","author":"Iorio","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000479948","article-title":"Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases","volume":"24","author":"Yang","year":"2017","journal-title":"Neuroimmunomodulation."},{"key":"B99","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.msard.2018.02.020","article-title":"Autoimmune GFAP astrocytopathy after viral encephalitis: a case report","volume":"21","author":"Li","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"B100","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year","volume":"321","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pediatrneurol.2016.04.004","article-title":"Antibody-mediated autoimmune encephalitis in childhood","volume":"60","author":"Brenton","year":"2016","journal-title":"Pediatr Neurol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","article-title":"Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges","volume":"30","author":"Dale","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/14737175.2016.1189328","article-title":"Diagnostic and therapeutic strategies for management of autoimmune encephalopathies","volume":"16","author":"Dubey","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaneurol.2016.2588","article-title":"Bortezomib treatment for patients with anti-N-Methyl-D-aspartate receptor encephalitis","volume":"73","author":"Behrendt","year":"2016","journal-title":"JAMA Neurol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dmcn.12545","article-title":"Intrathecal treatment of anti-N-Methyl-D-aspartate receptor encephalitis in children","volume":"57","author":"Tatencloux","year":"2015","journal-title":"Dev Med Child Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/dmcn.12882","article-title":"Symptomatic treatment of children with anti-NMDAR encephalitis","volume":"58","author":"Mohammad","year":"2016","journal-title":"Dev Med Child Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/WNL.8.6.435","article-title":"Focal seizures due to chronic localized encephalitis","volume":"8","author":"Rasmussen","year":"1958","journal-title":"Neurology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/B978-0-444-52891-9.00054-3","article-title":"Rasmussen encephalitis","volume":"111","author":"Granata","year":"2013","journal-title":"Handb Clin Neurol."},{"key":"B110","article-title":"Rasmussen's encephalitis","author":"Granata","year":"2019","journal-title":"Epileptic Syndrome in Infancy, Childhood and Adolescence"},{"key":"B111","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1212\/WNL.60.3.422","article-title":"Rasmussen's encephalitis: early characteristics allow diagnosis","volume":"60","author":"Granata","year":"2003","journal-title":"Neurology."},{"key":"B112","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1212\/WNL.56.2.248","article-title":"Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis","volume":"56","author":"Villani","year":"2001","journal-title":"Neurology."},{"key":"B113","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1528-1167.2006.00876.x","article-title":"Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases","volume":"47","author":"Villani","year":"2006","journal-title":"Epilepsia."},{"key":"B114","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.yebeh.2015.04.029","article-title":"The dilemma of adult-onset Rasmussen encephalitis clinical assessment: proposal for a new bedside tool to evaluate disease progression","volume":"46","author":"Deleo","year":"2015","journal-title":"Epilepsy Behav."},{"key":"B115","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.autrev.2017.05.022","article-title":"Late-onset Rasmussen encephalitis: a literature appraisal","volume":"16","author":"Dupont","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1212\/01.wnl.0000298723.96653.99","article-title":"Limited chronic focal encephalitis: another variant of Rasmussen syndrome?","volume":"70","author":"Gambardella","year":"2008","journal-title":"Neurology."},{"key":"B117","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jocn.2015.11.016","article-title":"Absence of seizures in Rasmussen encephalitis with active inflammation","volume":"28","author":"Samanta","year":"2016","journal-title":"J Clin Neurosci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1528-1157.1999.tb02082.x","article-title":"Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3","volume":"40","author":"Palmer","year":"1999","journal-title":"Epilepsia"},{"key":"B119","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000028811","article-title":"Coexistence of a ganglioglioma and Rasmussen's encephalitis","volume":"30","author":"Firlik","year":"1999","journal-title":"Pediatr Neurosurg."},{"key":"B120","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pediatrneurol.2016.10.001","article-title":"Anti-N-Methyl-D-Aspartate receptor encephalitis and Rasmussen-like syndrome: an association?","volume":"66","author":"Gurcharran","year":"2017","journal-title":"Pediatr Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/s-0034-1383822","article-title":"Voltage-gated potassium channels autoantibodies in a child with Rasmussen encephalitis","volume":"45","author":"Spitz","year":"2014","journal-title":"Neuropediatrics."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1212\/NXI.0000000000000150","article-title":"Pediatric anti-Hu-associated encephalitis with clinical features of Rasmussen encephalitis","volume":"2","author":"Aravamuthan","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B123","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/brain\/awh415","article-title":"Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement","volume":"128","author":"Bien","year":"2005","journal-title":"Brain."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1528-1167.2012.03565.x","article-title":"Evolution of the EEG in children with Rasmussen's syndrome","volume":"53","author":"Longaretti","year":"2012"},{"key":"B125","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00234-002-0923-7","article-title":"Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?","volume":"45","author":"Chiapparini","year":"2003","journal-title":"Neuroradiology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1528-1167.2011.03396.x","article-title":"Automated 3D MRI volumetry reveals regional atrophy differences in Rasmussen encephalitis","volume":"53","author":"Wagner","year":"2012","journal-title":"Epilepsia."},{"key":"B127","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.0013-9580.2004.33103.x","article-title":"The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies","volume":"45","author":"Pardo","year":"2004","journal-title":"Epilepsia."},{"key":"B128","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.seizure.2016.10.010","article-title":"Epilepsia partialis continua: a review","volume":"44","author":"Mameni\u0161kiene","year":"2017","journal-title":"Seizure"},{"key":"B129","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00019052-200204000-00012","article-title":"Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes","volume":"15","author":"Bauer","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.21148","article-title":"Astrocytes are a specific immunological target in Rasmussen's encephalitis","volume":"62","author":"Bauer","year":"2007","journal-title":"Ann Neurol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fimmu.2016.00064","article-title":"Evidence for resident memory T cells in Rasmussen encephalitis","volume":"7","author":"Owens","year":"2016","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/epi.12722","article-title":"Transition into adulthood: tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis","volume":"55","author":"Thiele","year":"2014","journal-title":"Epilepsia."},{"key":"B133","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/17425255.2019.1575361","article-title":"Pharmacokinetic considerations for anti-epileptic drugs in children","volume":"15","author":"Verrotti","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/14656566.2017.1323873","article-title":"Pediatric status epilepticus: improved management with new drug therapies?","volume":"18","author":"Verrotti","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1080\/14656566.2017.1373092","article-title":"Medical management for neurosurgical related seizures","volume":"18","author":"Ambrosi","year":"2017","journal-title":"Expert Opin Pharmacother."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.eplepsyres.2014.03.018","article-title":"Hemispherotomy in Rasmussen encephalitis: long-term outcome in an Italian series of 16 patients","volume":"108","author":"Granata","year":"2014","journal-title":"Epilepsy Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.eplepsyres.2009.09.006","article-title":"Hemispherotomy and functional hemispherectomy: indications and outcome","volume":"89","author":"Marras","year":"2010","journal-title":"Epilepsy Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2015.07.044","article-title":"Language recovery after left hemispherotomy for Rasmussen encephalitis","volume":"53","author":"Bulteau","year":"2015","journal-title":"Epilepsy Behav."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1111\/epi.12596","article-title":"Long-term outcome after limited cortical resections in two cases of adult-onset Rasmussen encephalitis","volume":"55","author":"Villani","year":"2014","journal-title":"Epilepsia."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1212\/01.WNL.0000099074.04539.E0","article-title":"Experience with immunomodulatory treatments in Rasmussen's encephalitis","volume":"61","author":"Granata","year":"2003","journal-title":"Neurology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nrneurol.2009.98","article-title":"A case of Rasmussen encephalitis treated with rituximab","volume":"5","author":"Thilo","year":"2009","journal-title":"Nat Rev Neurol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1212\/WNL.0b013e31829c5ceb","article-title":"Rasmussen encephalitis treated with natalizumab","volume":"81","author":"Bittner","year":"2013","journal-title":"Neurology."},{"key":"B143","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/epi.13387","article-title":"Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: an open pilot study","volume":"57","author":"Lagarde","year":"2016","journal-title":"Epilepsia."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1111\/ene.13795","article-title":"Adult-onset Rasmussen encephalitis treated with mitoxantrone","volume":"25","author":"Stabile","year":"2018","journal-title":"Eur J Neurol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jclinpath-2016-203810","article-title":"Autoinflammatory diseases: update on classification diagnosis and management","volume":"70","author":"Pathak","year":"2017","journal-title":"J Clin Pathol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.berh.2017.12.002","article-title":"Genetic interferonopathies: an overview","volume":"31","author":"Eleftheriou","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/ane.13130","article-title":"Epileptic phenotypes in children with early onset mitochondrial diseases","volume":"140","author":"Matricardi","year":"2019","journal-title":"Acta Neurol Scand."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10072-014-1701-0","article-title":"Anticonvulsant drugs and hematological disease","volume":"35","author":"Verrotti","year":"2014","journal-title":"Neurol Sci"},{"key":"B150","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40272-018-0302-4","article-title":"Pharmacokinetics and drug interaction of antiepileptic drugs in children and adolescents","volume":"20","author":"Iapadre","year":"2018","journal-title":"Paediatr Drugs."},{"key":"B151","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.phrs.2016.04.006","article-title":"Management of genetic epilepsies: from empirical treatment to precision medicine","volume":"107","author":"Striano","year":"2016","journal-title":"Pharmacol Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1172\/JCI121526","article-title":"JAK inhibitors in autoinflammation","volume":"128","author":"Hoffman","year":"2018","journal-title":"J Clin Invest."},{"key":"B153","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11926-018-0792-7","article-title":"JAK inhibitors in rheumatology: implications for paediatric syndrome?","volume":"20","author":"Kerrigan","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B154","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1212\/WNL.0b013e31824f800a","article-title":"CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis","volume":"78","author":"Deiva","year":"2012","journal-title":"Neurology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:34:17Z","timestamp":1576730057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":157,"alternative-id":["10.3389\/fped.2019.00511"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00511","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"article-number":"511"}}